These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38997885)

  • 1. Regional Differences and Temporal Changes in the Utilization of HCV-Viremic Donors in Kidney Transplantation.
    Leeaphorn N; Attieh RM; Wadei HM; Mao SA; Mao MA; Pungpapong S; Taner B; Cheungpasitporn W; Jarmi T
    Transplant Proc; 2024; 56(6):1513-1521. PubMed ID: 38997885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.
    Bowring MG; Shaffer AA; Massie AB; Cameron A; Desai N; Sulkowski M; Garonzik-Wang J; Segev DL
    Am J Transplant; 2019 Aug; 19(8):2329-2341. PubMed ID: 30861279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.
    Potluri VS; Goldberg DS; Mohan S; Bloom RD; Sawinski D; Abt PL; Blumberg EA; Parikh CR; Sharpe J; Reddy KR; Molnar MZ; Sise M; Reese PP
    J Am Soc Nephrol; 2019 Oct; 30(10):1939-1951. PubMed ID: 31515244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal changes in the utilization of kidneys from hepatitis C virus-infected donors in the United States.
    Buchanan-Peart KA; Pagan J; Martin E; Turkeltaub J; Reese P; Goldberg DS
    Am J Transplant; 2023 Jun; 23(6):831-838. PubMed ID: 36893936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Underlying Racial Disparity in Utilization of Hepatitis C-Viremic Kidneys in the United States.
    Atiemo K; Baudier R; Craig-Schapiro R; Guo K; Mazumder N; Anderson A; Zhao L; Ladner D
    J Racial Ethn Health Disparities; 2023 Oct; 10(5):2185-2194. PubMed ID: 35997960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard.
    Ariyamuthu VK; Sandikci B; AbdulRahim N; Hwang C; MacConmara MP; Parasuraman R; Atis A; Tanriover B
    Transpl Infect Dis; 2020 Feb; 22(1):e13204. PubMed ID: 31677214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.
    La Hoz RM; Sandıkçı B; Ariyamuthu VK; Tanriover B
    Am J Transplant; 2019 Nov; 19(11):3058-3070. PubMed ID: 31207073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
    Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
    Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States.
    Chang SH; Merzkani M; Lentine KL; Wang M; Axelrod DA; Anwar S; Schnitzler MA; Wellen J; Chapman WC; Alhamad T
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):251-261. PubMed ID: 33451990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation.
    Cotter TG; Aronsohn A; Reddy KG; Charlton M
    Transplantation; 2021 Jun; 105(6):1285-1290. PubMed ID: 32639400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.
    Sibulesky L; Kling CE; Blosser C; Johnson CK; Limaye AP; Bakthavatsalam R; Leca N; Perkins JD
    Am J Transplant; 2018 Oct; 18(10):2465-2472. PubMed ID: 29451354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation.
    Da BL; Ezaz G; Kushner T; Crismale J; Kakked G; Gurakar A; Dieterich D; Schiano TD; Saberi B
    JAMA Netw Open; 2020 Dec; 3(12):e2027551. PubMed ID: 33275155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race, Education, and Gender Disparities in Transplantation of Kidneys From Hepatitis C Viremic Donors.
    Nguyen T; Sise ME; Delgado C; Williams W; Reese P; Goldberg D
    Transplantation; 2021 Aug; 105(8):1850-1857. PubMed ID: 33141804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the use of hepatitis C viremic donor hearts.
    Li SS; Osho A; Moonsamy P; D'Alessandro DA; Lewis GD; Villavicencio MA; Sundt TM; Funamoto M
    J Thorac Cardiovasc Surg; 2022 May; 163(5):1873-1885.e7. PubMed ID: 33487431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
    Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
    Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.
    Kwong AJ; Wall A; Melcher M; Wang U; Ahmed A; Subramanian A; Kwo PY
    Am J Transplant; 2019 May; 19(5):1380-1387. PubMed ID: 30378723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and Gender Disparities in Transplantation of Hepatitis C+ Hearts and Lungs.
    Hannan HA; Goldberg DS
    J Heart Lung Transplant; 2024 May; 43(5):780-786. PubMed ID: 38163451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
    Czarnecka P; Czarnecka K; Tronina O; Baczkowska T; Durlik M
    Ren Fail; 2022 Dec; 44(1):434-449. PubMed ID: 35260039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated impact of hepatitis C-positive lung donor utilization on US donor lung supply.
    Mooney JJ; Purington N; Mohabir P; Dhillon GS
    Am J Transplant; 2020 Jan; 20(1):289-297. PubMed ID: 31394016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.
    Friebus-Kardash J; Gäckler A; Kribben A; Witzke O; Wedemeyer H; Treckmann J; Herzer K; Eisenberger U
    Transpl Infect Dis; 2019 Oct; 21(5):e13146. PubMed ID: 31306562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.